Close

Analyst Ratings for Acadia Pharmaceuticals (ACAD)

ACAD Rating Summary

ACAD Price Target Summary

* Over Last 12-Mos
  |   Expand Research on ACAD
Overall Rating: NEUTRAL   Rating Trend: =   Avg. $ Target: $32.84 (+38.3%) * Over Last 12-Mos
Rating Score: 5.6 / 10   Percentile Rank: 60%
Date Firm Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
1/30/2024 Baird Joel Beatty New Coverage Outperform
(N/A)
40.00
(N/A)
26.94
(23.75)
-11.84% Details
1/24/2024 Needham
» Updated 2/28/2024
Ami Fadia Upgrade Buy
(Hold)
36.00
(37.00)
28.15
(23.75)
-15.63% Details
Like ACAD Ratings? Also take a look at FSLR, NEU, LNTH, CTVA

ACAD Ratings News